45 related articles for article (PubMed ID: 12952762)
1. The immunological effects of taxanes.
Chan OT; Yang LX
Cancer Immunol Immunother; 2000 Jul; 49(4-5):181-5. PubMed ID: 10941900
[TBL] [Abstract][Full Text] [Related]
2. What is the origin of these nail changes in an otherwise healthy young patient?
Webb A; Kerns W
J Med Toxicol; 2009 Mar; 5(1):31, 39. PubMed ID: 19343825
[No Abstract] [Full Text] [Related]
3. 'Shrimp nail' - stacked vertical curvature of the nail plate occurring as a potential side-effect of tumour necrosis factor-alpha inhibitor use.
Kearney N; Roche M
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839417
[No Abstract] [Full Text] [Related]
4. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
[TBL] [Abstract][Full Text] [Related]
5. Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients.
Emvalomati A; Oflidou V; Papageorgiou C; Kemanetzi C; Giannouli M; Kalloniati E; Efthymiadis K; Koukoutzeli C; Timotheadou E; Trigoni A; Patsatsi A; Lazaridou E; Apalla Z; Trakatelli M
Dermatol Pract Concept; 2023 Jan; 13(1):. PubMed ID: 36892360
[TBL] [Abstract][Full Text] [Related]
6. Nail Changes Induced by Chemotherapeutic Agents.
Saraswat N; Sood A; Verma R; Kumar D; Kumar S
Indian J Dermatol; 2020; 65(3):193-198. PubMed ID: 32565559
[TBL] [Abstract][Full Text] [Related]
7. Dermatological adverse events with taxane chemotherapy.
Sibaud V; Lebœuf NR; Roche H; Belum VR; Gladieff L; Deslandres M; Montastruc M; Eche A; Vigarios E; Dalenc F; Lacouture ME
Eur J Dermatol; 2016 Oct; 26(5):427-443. PubMed ID: 27550571
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-induced nail dystrophy.
Nicolopoulos J; Howard A
Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
[TBL] [Abstract][Full Text] [Related]
9. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature.
Hussain S; Anderson DN; Salvatti ME; Adamson B; McManus M; Braverman AS
Cancer; 2000 May; 88(10):2367-71. PubMed ID: 10820360
[TBL] [Abstract][Full Text] [Related]
10. Nail toxicity related to taxanes.
Mourad YA; Matta-Muallem M; Shamseddine A
Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
[TBL] [Abstract][Full Text] [Related]
11. [Taxane-induced ungual anomalies].
Schmutz JL; Barbaud A; Tréchot P
Ann Dermatol Venereol; 2000 Jan; 127(1):130. PubMed ID: 10717580
[No Abstract] [Full Text] [Related]
12. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
Llombart-Cussac A; Pivot X; Spielmann M
Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
[No Abstract] [Full Text] [Related]
13. Nail toxicity associated with paclitaxel treatment for ovarian cancer.
Swenson KK; Bell EM; Nissen J
Oncol Nurs Forum; 2013 Jan; 40(1):17-9. PubMed ID: 23269765
[No Abstract] [Full Text] [Related]
14. Docetaxel-related skin, nail, and vascular toxicity.
Leonard GD; Zujewski JA
Ann Pharmacother; 2003 Jan; 37(1):148. PubMed ID: 12564432
[No Abstract] [Full Text] [Related]
15. Clinical picture: nail changes secondary to docetaxel.
Wasner G; Hilpert F; Baron R; Pfisterer J
Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
